Hopson Group To Acquire A Unit At Evergrande
China’s Evergrande will offer a half interest in its real estate division to Hopson Development for about USD 5 billion (HKD 40 billion). Evergrande Real...
COVID-19 Tablet From Merck Reduces Mortality And Illness By 50%
According to intermediate test reports released on Friday, Merck & Co Inc's oral medication for COVID-19, Molnupiravir, lowered the likelihood of hospitalization or fatality in...
China’s Electric Vehicle Companies Target Europe
With Europe's push for green energy, China's battery-powered car companies are racing into Europe, hoping to surprise established automakers. On Thursday, Nio Inc, one of...
OPEC+ Is Helpless About Preventing Oil Price Surge
Few could have imagined that after an unusually lengthy bull run this year on the back of growing consumption, oil prices would continue to rise...
BoE: Rate Increase May Be Earlier Than Anticipated
After deliberating at its September meeting, the Bank of England (BoE) determined that the current stance of monetary policy was acceptable. Despite the 'modest tightening'...
Crude Price Prediction: Five Day Rally Matches July Peak
After breaking out of the falling range earlier this year, oil prices appear to be on track to challenge the yearly high ($76.98), and anticipated...
Will The New iPhone 13 Boost Apple (AAPL) Stock Price?
Apple's share price remained virtually unchanged on Friday as financial markets sought orientation after an upheaval week marked by plenty of volatility. Investors were concerned...
Stocks Rise As The Greenback Drops
Worldwide stocks markets revitalized on Thursday, while the dollar plunged from one-month highs as worries about overflow from China's Evergrande behemoth died down and investors...
Two Undervalued Equities to Buy Immediately
For the second consecutive day, the three major market indexes finished significantly greater on Thursday, rebounding from previously this week's pullback. The bullishness implies that...
Astrazeneca Investing In Imperial’s Self-amplifying RNA Innovation
AstraZeneca Plc announced on Thursday that it has reached an agreement with the company behind the exploratory COVID-19 immunization developed by Imperial College London to...